NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has entered into an agreement with holders of its $1.75 million senior secured debenture, paying off the secured loan and regaining all rights to its assets.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.